Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prothymosin alpha pseudogene 12 (PTMAP12) is a human processed pseudogene derived from the protein-coding prothymosin alpha (PTMA) gene, localized on chromosome 9. Unlike its parental gene, PTMAP12 is not believed to encode a functional protein. However, expression of PTMAP12 has been observed in some cancers, and recent transcriptomic analysis has identified PTMAP12 as a novel pseudogene with elevated expression in acute myeloid leukemia compared to chronic myeloid leukemia, but not in healthy individuals. Its function remains unclear, but as with other pseudogenes, PTMAP12 may potentially regulate gene expression or participate in oncogenic biology in cancer cells[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prothymosin alpha pseudogene 12 (PTMAP12).